Automated insulin delivery before and during pregnancy for type 1 diabetes
Part of Women’s health & pregnancy clinical trials.
This trial tests whether an automated insulin delivery system can improve blood sugar control compared to usual insulin methods before and during pregnancy in women with type 1 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 45.
- You have had type 1 diabetes for at least 12 months.
- If you are planning pregnancy, you are not pregnant now and plan to become pregnant within the next 52 weeks.
- If you are already pregnant, you have a single baby confirmed by ultrasound at 8 to 13 weeks.
- You can understand and speak Danish well enough to follow instructions.
- You have no severe mental or other health problems that would make participation unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This study helps pregnant women with type 2 diabetes receive better blood sugar management during pregnancy. Researchers will monitor you and your baby closely to see how well the treatment plan works and keeps both of you healthy.
This study tests if an automated insulin delivery system can help manage blood sugar levels during labor and delivery in pregnant women with type 1 diabetes. If successful, it could make the process safer and easier.
This study looks at how automated insulin delivery systems (closed-loop pumps) work during pregnancy for women with type 1 diabetes. It aims to understand how these systems can help manage blood sugar levels safely for both you and your baby.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study compares a new automated insulin delivery algorithm (AIDANET) in two modes: fully closed-loop (no user input needed) versus hybrid closed-loop (user still gives some insulin for meals). It tests how well the algorithm works in real-life settings for adults with type 1 diabetes.
Hear when a new Pregnancy Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.